Application of crisaborole ointment in dermatology
- VernacularTitle:克立硼罗软膏在皮肤科中的应用进展
- Author:
Siyan YANG
1
;
Lin MA
;
Bin ZHANG
Author Information
- Keywords: Cyclic nucleotide phosphodiesterases, type 4; Phosphodiesterase-4 inhibitor; Crisaborole ointment; Skin diseases; Therapy; Dermatitis, atopic; Psoriasis; Vit
- From: Chinese Journal of Dermatology 2024;57(10):962-966
- CountryChina
- Language:Chinese
- Abstract: Crisaborole, a phosphodiesterase-4 inhibitor, has been approved for the treatment of mild to moderate atopic dermatitis in China. In addition, crisaborole ointment has been reported for the successful treatment of other inflammatory skin disorders. This review summarizes mechanisms of action of crisaborole and its application to the treatment of atopic dermatitis, psoriasis, vitiligo, seborrheic dermatitis, inflammatory linear verrucous epidermal nevus, lichen simplex chronicus, prurigo pigmentosa, alopecia areata, plasma cell balanitis, and lichen planus.
